155 related articles for article (PubMed ID: 18377388)
21. Venlafaxine-induced serotonin syndrome with relapse following amitriptyline.
Perry NK
Postgrad Med J; 2000 Apr; 76(894):254-6. PubMed ID: 10727586
[TBL] [Abstract][Full Text] [Related]
22. Serotonin Syndrome With the Concomitant Use of Triptans and SSRIs/Serotonergic Medications: Is It Time to Revisit FDA Warning?
Mansuri Z; Adnan M; Shah B; Trivedi C; Vadukapuram R; Patel S; Yadav G; Srinivas S; Ansari M; Makani R; Baweja R; Reddy A
J Clin Psychopharmacol; 2024 Mar-Apr 01; 44(2):199-200. PubMed ID: 38227629
[No Abstract] [Full Text] [Related]
23. Is an FDA alert harming patients?
Schuman E
JAAPA; 2009 May; 22(5):55. PubMed ID: 19469393
[No Abstract] [Full Text] [Related]
24. The Diagnostic clinical Interview for Drug Withdrawal 1 (DID-W1) – New Symptoms of Selective Serotonin Reuptake Inhibitors (SSRI) or Serotonin Norepinephrine Reuptake Inhibitors (SNRI): inter-rater reliability.
Cosci F; Chouinard G; Chouinard VA; Fava GA
Riv Psichiatr; 2018; 53(2):95-99. PubMed ID: 29674777
[TBL] [Abstract][Full Text] [Related]
25. Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: A systematic review and meta-analysis.
Khanassov V; Hu J; Reeves D; van Marwijk H
Int J Geriatr Psychiatry; 2018 Dec; 33(12):1688-1708. PubMed ID: 30247774
[TBL] [Abstract][Full Text] [Related]
26. [Hyponatremia associated with SSRI/NRSI: Descriptive and comparative epidemiological study of the incidence rates of the notified cases from the data of the French National Pharmacovigilance Database and the French National Health Insurance].
Revol R; Rault C; Polard E; Bellet F; Guy C
Encephale; 2018 Jun; 44(3):291-296. PubMed ID: 29248119
[TBL] [Abstract][Full Text] [Related]
27. [SSRI and SNRI treatment in children and adolescents. Current views of the benefits and risks].
Holtkamp K; Herpertz-Dahlmann B
Nervenarzt; 2008 Nov; 79(11):1237-8, 1240, 1243-4, passim. PubMed ID: 18958442
[TBL] [Abstract][Full Text] [Related]
28. [Serotonergic syndrome in combination of linezolid (Zyvixid) and SSRI].
Schwan S; Hallberg P
Lakartidningen; 2009 Oct 28-Nov 3; 106(44):2856. PubMed ID: 19967965
[No Abstract] [Full Text] [Related]
29. SSRI/SNRI Use is Not Associated with Increased Risk of Delayed Cerebral Ischemia After aSAH.
Young JB; Singh TD; Rabinstein AA; Fugate JE
Neurocrit Care; 2016 Apr; 24(2):197-201. PubMed ID: 26264066
[TBL] [Abstract][Full Text] [Related]
30. Linezolid and serotonergic drug interactions: a retrospective survey.
Taylor JJ; Wilson JW; Estes LL
Clin Infect Dis; 2006 Jul; 43(2):180-7. PubMed ID: 16779744
[TBL] [Abstract][Full Text] [Related]
31. Serotonin toxicity revisited.
Schuman E
Headache; 2009 May; 49(5):784-5. PubMed ID: 19456889
[No Abstract] [Full Text] [Related]
32. Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review.
Gillman PK
Headache; 2010 Feb; 50(2):264-72. PubMed ID: 19925619
[TBL] [Abstract][Full Text] [Related]
33. Myelosuppression and serotonin syndrome associated with concurrent use of linezolid and selective serotonin reuptake inhibitors in bone marrow transplant recipients.
Hachem RY; Hicks K; Huen A; Raad I
Clin Infect Dis; 2003 Jul; 37(1):e8-11. PubMed ID: 12830431
[TBL] [Abstract][Full Text] [Related]
34. Triptan migraine treatments and antidepressants: risk of serotonin syndrome.
Wooltorton E
CMAJ; 2006 Oct; 175(8):874. PubMed ID: 16988028
[No Abstract] [Full Text] [Related]
35. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.
Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T
CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116
[TBL] [Abstract][Full Text] [Related]
36. Selective serotonin reuptake inhibitor syndrome: precipitated by concomitant clozapine?
Lu ML; Lane HY; Chang WH
J Clin Psychopharmacol; 1999 Aug; 19(4):386-7. PubMed ID: 10440475
[No Abstract] [Full Text] [Related]
37. Multiple drug interactions - induced serotonin syndrome: a case report.
Montané E; Barriocanal A; Isern I; Parajon T; Costa J
J Clin Pharm Ther; 2009 Aug; 34(4):485-7. PubMed ID: 19583682
[TBL] [Abstract][Full Text] [Related]
38. Drug interactions with triptans : which are clinically significant?
Rolan PE
CNS Drugs; 2012 Nov; 26(11):949-57. PubMed ID: 23018546
[TBL] [Abstract][Full Text] [Related]
39. Serotonin syndrome and the use of SSRIs.
Finfgeld DL
J Psychosoc Nurs Ment Health Serv; 2004 Feb; 42(2):16-20. PubMed ID: 14982105
[TBL] [Abstract][Full Text] [Related]
40. Serotonin syndrome with mirtazapine-fluoxetine combination.
Benazzi F
Int J Geriatr Psychiatry; 1998 Jul; 13(7):495-6. PubMed ID: 9695042
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
